Qiagen N.V.

QGEN: NYSE
48Total

Lowest reading is at 7 out of 100. All scores are out of 100.

About The Company

CEO

Mr. Jonathan M. Pratt

Market Cap

9.53 Billion USD

Sector

Healthcare

Website

https://www.qiagen.com

Last Update

15/10/2026, 01:01:49

Description

Qiagen N.V.

Read More

Strongest readings

  • ✔Financial health is strong (health score 77 out of 100)
  • ✔Debt is low at 0.48 times equity
  • ✔Altman-Z score of 3.75 sits above the distress range

Weakest readings

  • ✘Revenue is growing at 0.66% per year while free cashflow is falling
  • ✘Earnings and cashflow growth is weak (growth score 7 out of 100)
  • ✘The current price sits above estimated fair value (margin of safety -64.17%)
  • ✘Returns on capital have declined over five years (3.86% lower)
  • ✘Price-to-earnings of 22.9 is above the market average of 19.6

Key Figures

StatusMetricValueReadingMarket avg
✘
Price / earnings (TTM)
22.86x
19.60x
✘
Margin of safety (DCF)
-64.17%
17.95%
✘
Revenue growth (5y average)
0.66%
10.97%
Dividend yield (TTM)
N/A1.85%
✘
Share count, per year
0.40%
0.00%
✘Return on capital employed9.07%
10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

44 / 100

Priced above the market on most measures.

StatusMetricValueReadingMarket avg
✘
Price / earnings
22.86x
19.60x
✔Free cashflow yield4.70%
4.70%
✔Price / earnings growth0.06x
1.50x
Price / book2.79x
—
✘
Margin of safety
-64.17%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Estimated intrinsic value of 16.26 USD is below the current price of 46.13 USD

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: 37.7 USD ✘

Current Price: 45.4 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

7 / 100

Growing more slowly than the market on most measures.

StatusMetricValueReadingMarket avg
✘
Revenue growth
0.66%
10.97%
✘Earnings growth-40.88%
14.48%
✘Cashflow growth-10.97%
12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Revenue is growing at 0.66% per year while free cashflow is falling at 10.97% per year

Health

77 / 100

Balance sheet covers its obligations.

Measured on Leverage and capital, Funding and liquidity, Earnings quality.

StatusMetricValueReadingThreshold
✔Altman-Z score3.75
3.00
✔Piotroski score6.00
5.00
✔Debt / equity0.48x
0.80x
✔Current ratio3.90x
1.00x
✔Interest coverage15.74x
2.50x
✔Free cashflow / debt0.25x
0.15x
✔Debt / capital0.32x
1.00x

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Dividend

    38 / 100

    Cover is thin on at least one measure.

    StatusMetricValueReadingMarket avg
    ✘
    Dividend yield
    0.19%
    1.85%
    Dividend growthN/A0.00%
    ✔Payout ratio (earnings)4.26%
    40.00%
    ✔Payout ratio (cashflow)3.99%
    65.00%
    Worst year, last 5 yearsN/A-2.00%

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

      Management

      63 / 100

      Returns on capital are at or above the market.

      StatusMetricValueReadingMarket avg
      ✘Return on equity11.25%
      15.00%
      ✘Return on capital employed9.07%
      10.00%
      Return on assets6.76%
      —
      Free cashflow return on capital7.75%
      —
      ✘Return on capital, 5y change-3.86%
      0.00%
      ✘
      Share count, per year
      0.40%
      0.00%
      ✘Share count, recent0.07%
      0.00%
      Realized buyback returnN/A0.00%
      ✔Goodwill erosion / equity1.33%
      2.00%
      Price volatility, 5 year26.38%
      —

      The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

      • ✔New shares were issued while the value score was 44 out of 100

      Analysts

      not enough data
      StatusMetricValueReadingNeutral
      Analyst opinion scoreN/A50

      The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

      Financial History

      Annual figures across the full reporting history we hold.

      Market Peers

      QGEN

      SEC Filings

      Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

      See 35+ Years Annual Reports

      Other Information

      Company Name

      Qiagen N.V.

      Currency

      USD

      Beta

      0.626

      Vol Avg

      2695858

      Ceo

      Mr. Jonathan M. Pratt

      Cik

      0001015820

      Cusip

      Exchange

      NYSE

      Full Time Employees

      5500

      Industry

      Diagnostics & Research

      Sector

      Healthcare

      Ipo Date

      Address

      Hulsterweg 82

      City

      Venlo

      State

      Country

      Netherlands

      Zip

      5912 PL

      Phone

      31 77 355 6600

      Analysis Last Updated

      15/10/2026, 01:01:49

      Financial data compiled from SEC EDGAR filings and Yahoo Finance.

      Noticed an error with something on our site?

      Data, not advice. Do your own diligence.

      We Use Cookies